This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Assessment of Pancreas Safety in the Development Program of Once-Weekly GLP-1 Receptor Agonist Dulaglutide.
Diabetes care, 40(5), 647-654
Citation
Nauck, Michael A; Frossard, Jean-Louis; Barkin, Jamie S; Anglin, Greg; Hensley, Ingrid E; Harper, Kristine D; Milicevic, Zvonko. (2017). Assessment of Pancreas Safety in the Development Program of Once-Weekly GLP-1 Receptor Agonist Dulaglutide.. Diabetes care, 40(5), 647-654. https://doi.org/10.2337/dc16-0984